阿帕替尼治療EGFR 20外顯子766插入突變晚期NSCLC 1例
發(fā)布時(shí)間:2018-03-14 03:03
本文選題:阿帕替尼 切入點(diǎn):晚期非小細(xì)胞肺癌 出處:《中國(guó)腫瘤臨床》2017年05期 論文類型:期刊論文
【摘要】:正患者女性,39歲。2013年12月因"無(wú)誘因咳嗽、咽痛進(jìn)行性加重,痰中無(wú)血"就診于天津醫(yī)科大學(xué)腫瘤醫(yī)院。患者自述無(wú)吸煙史;自查發(fā)現(xiàn)左鎖上多發(fā)質(zhì)硬腫大淋巴結(jié),最大約為1.5 cm。2014年3月CEA 9.55μg/L(正常范圍0~5μg/L)。胸部CT示:1)右肺下葉背段不規(guī)則腫物,考慮周圍型肺癌,牽拉鄰近胸膜;2)雙肺多發(fā)結(jié)節(jié),考慮轉(zhuǎn)移瘤;3)左鎖上淋巴結(jié)。腦部CT示:顱腦CT未見(jiàn)確切異常。ECT示:未見(jiàn)明顯骨轉(zhuǎn)移
[Abstract]:In December 2013, she was admitted to Tianjin Medical University Oncology Hospital because of "no cause of cough, progressive aggravation of pharynx pain, no blood in sputum". The patient reported no smoking history. Self-examination found that the left locus had more hair and enlarged lymph nodes. The maximum value was about 1. 5 cm.2014 March CEA 9. 55 渭 g / L (normal range 0 5 渭 g / L). Irregular masses in the lower lobe of the right lung, considering peripheral lung cancer and drawing adjacent to the pleura (2), had multiple nodules in both lungs. Consider metastatic tumor 3) left supraclavicular lymph node. Brain CT: no exact abnormality. ECT: no obvious bone metastasis.
【作者單位】: 天津醫(yī)科大學(xué)腫瘤醫(yī)院生物治療科 國(guó)家腫瘤臨床醫(yī)學(xué)研究中心 天津市腫瘤防治重點(diǎn)實(shí)驗(yàn)室 天津市惡性腫瘤臨床醫(yī)學(xué)研究中心;
【分類號(hào)】:R734.2
,
本文編號(hào):1609312
本文鏈接:http://sikaile.net/yixuelunwen/zlx/1609312.html
最近更新
教材專著